Selby, Philip Roland http://orcid.org/0000-0002-5647-4673
Shakib, Sepehr
Peake, Sandra L.
Warner, Morgyn S.
Yeung, David
Hahn, Uwe
Roberts, Jason A.
Funding for this research was provided by:
Australian Government - Research Training Program Scholarship
Article History
Accepted: 24 December 2020
First Online: 30 January 2021
Declarations
:
: Philip R. Selby is the recipient of an Australian Government Research Training Program Scholarship.
: Philip R. Selby has received financial support from Merck Sharp & Dohme to attend symposia. David Yeung has received honoraria from Novartis, Bristol Myers Squibb, Pfizer, Amgen and Takeda, and research funding from Novartis and Bristol Myers Squibb. Jason A. Roberts has received grants, consultancies or speaker fees from Biomerieux, Merck Sharp & Dohme, Discuva, Accelerate Diagnostics, The Medicines Company, Qpex and Pfizer. Sepehr Shakib, Sandra L. Peake, Morgyn S. Warner and Uwe Hahn have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: PS, SS, MW and JR conceived the presented idea. PS and SS undertook the database search, determined study eligibility for the review and extracted the relevant data from the studies for review. PS, SS, SP, MW, DY, UH and JR evaluated and interpreted the included studies. PR wrote the first draft of the manuscript and critical revision was undertaken by SS, SP, MW, DY, UH and JR. All authors read and approved the final version of the manuscript.